熱門資訊> 正文
SBFM、BPATH和INDO均为上市前输家
2024-04-22 20:23
- Sunshine Biopharma Inc Ordinary Shares(SBFM) 0
- Bio-Path控股(BPTH) 0
- Indonesia Energy Corp Ltd.(INDO) 0
- Losers: Hepion Pharmaceuticals (HEPA) -38% initiates wind-down activities in Phase 2b ‘ASCEND-NASH’ trial.
- Top Wealth Group Holding Limited (TWG) -17%.
- Redwoods Acquisition Corp (RWOD) -13%.
- Sunshine Biopharma (SBFM) -12%.
- MediaCo Holding (MDIA) -11%.
- Indonesia Energy Corp Ltd (INDO) -11%.
- Bio-Path Holdings (BPTH) -9%.
- INVO Bioscience (INVO) -9%.
- Li Auto (LI) -7% shares slide after matching Tesla price cuts.
- Edible Garden (EDBL) -7%.
- Mobile health Network Solutions (MNDR) -3%.
- Endeavour Silver Corp. (EXK) -7% celebrates Milestone: Terronera surpasses 50% construction completion.
- Zhongchao (ZCMD) -6%.
- First Majestic Silver Corporation (AG) -6%.
- Coeur Mining (CDE) -6%.
- Hub Cyber Security Ltd (HUBC) -6%.
- Nova Lifestyle (NVFY) -6%.
- Harmony Gold Mining Co Ltd (HMY) -6%.
- Pan American Silver Corp (PAAS) -6%.
- Vizsla Silver Corp (VZLA) -6%.
- AngloGold Ashanti (AU) -6%.
- MAG Silver Corp. (MAG) -5%.
- Chromocell Therapeutics Corp. (CHRO) -5%.
More on pre-market losers & stocks.
- Bio-Path Holdings Inc. (BPTH) Q4 2023 Earnings Call Transcript
- Bio-Path announces $1.2M registered direct offering priced at-the-market
- Bio-Path shares rally after clinical trial progress of BP1002
- Seeking Alpha’s Quant Rating on Bio-Path
- Historical earnings data for Bio-Path
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
